These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30349604)

  • 1. Sleeping Beauty or the Beast? - Metabolic Syndrome from an Obstructive Sleep Apnoea Perspective.
    Tarnow L; Klinkenbijl B; Woehrle H
    Eur Endocrinol; 2013 Mar; 9(1):12-17. PubMed ID: 30349604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management.
    Farrell PC; Richards G
    J Transl Med; 2017 May; 15(1):114. PubMed ID: 28545542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome.
    Seetho IW; Wilding JP
    Chron Respir Dis; 2014 Nov; 11(4):257-75. PubMed ID: 25281562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular responses to hypoxia are not impaired in obstructive sleep apnoea patients free of overt cardiovascular disease.
    Beaudin AE; Hanly PJ; Raneri JK; Sajobi TT; Anderson TJ; Poulin MJ
    Exp Physiol; 2019 Apr; 104(4):580-600. PubMed ID: 30697840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular consequences of obstructive sleep apnoea.
    Kuniyoshi FH; Pusalavidyasagar S; Singh P; Somers VK
    Indian J Med Res; 2010 Feb; 131():196-205. PubMed ID: 20308745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial.
    Sánchez-de-la-Torre M; Sánchez-de-la-Torre A; Bertran S; Abad J; Duran-Cantolla J; Cabriada V; Mediano O; Masdeu MJ; Alonso ML; Masa JF; Barceló A; de la Peña M; Mayos M; Coloma R; Montserrat JM; Chiner E; Perelló S; Rubinós G; Mínguez O; Pascual L; Cortijo A; Martínez D; Aldomà A; Dalmases M; McEvoy RD; Barbé F;
    Lancet Respir Med; 2020 Apr; 8(4):359-367. PubMed ID: 31839558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease.
    McNicholas WT
    J Thorac Dis; 2018 Dec; 10(Suppl 34):S4253-S4261. PubMed ID: 30687541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive sleep apnoea and cardiovascular disease.
    Sánchez-de-la-Torre M; Campos-Rodriguez F; Barbé F
    Lancet Respir Med; 2013 Mar; 1(1):61-72. PubMed ID: 24321805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk.
    Resano-Barrio MP; Arroyo-Espliguero R; Viana-Llamas MC; Mediano O
    Eur Cardiol; 2020 Feb; 15():e65. PubMed ID: 33042228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?
    Vgontzas AN
    Arch Physiol Biochem; 2008 Oct; 114(4):211-23. PubMed ID: 18946782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obstructive sleep apnoea and type 2 diabetes mellitus].
    Plíhalová A; Westlake K; Polák J
    Vnitr Lek; 2016; 62(11 Suppl 4):S79-84. PubMed ID: 27921430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of obstructive sleep apnoea in REM behaviour disorder: response to continuous positive airway pressure therapy.
    Gabryelska A; Roguski A; Simpson G; Maschauer EL; Morrison I; Riha RL
    Sleep Breath; 2018 Sep; 22(3):825-830. PubMed ID: 28951996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in sympathetic tone in patients with obstructive sleep apnoea: is fixed CPAP more effective than APAP? A randomised, parallel trial protocol.
    Treptow E; Pepin JL; Bailly S; Levy P; Bosc C; Destors M; Woehrle H; Tamisier R
    BMJ Open; 2019 Apr; 9(4):e024253. PubMed ID: 30948567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous positive airway pressure and isocapnic-hypoxia on cerebral autoregulation in patients with obstructive sleep apnoea.
    Waltz X; Beaudin AE; Hanly PJ; Mitsis GD; Poulin MJ
    J Physiol; 2016 Dec; 594(23):7089-7104. PubMed ID: 27644162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular mechanisms and consequences of obstructive sleep apnoea.
    Vrints H; Shivalkar B; Hilde H; Vanderveken OM; Hamans E; Van de Heyning P; De Backer W; Verbraecken J
    Acta Clin Belg; 2013; 68(3):169-78. PubMed ID: 24156215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study.
    Hall AB; Ziadi MC; Leech JA; Chen SY; Burwash IG; Renaud J; deKemp RA; Haddad H; Mielniczuk LM; Yoshinaga K; Guo A; Chen L; Walter O; Garrard L; DaSilva JN; Floras JS; Beanlands RS
    Circulation; 2014 Sep; 130(11):892-901. PubMed ID: 24993098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Continuous Positive Airway Pressure on Lipidaemia and High-sensitivity C-reactive Protein Levels in Non-obese Patients with Coronary Artery Disease and Obstructive Sleep Apnoea.
    Huang Z; Liu Z; Zhao Z; Zhao Q; Luo Q; Tang Y
    Heart Lung Circ; 2016 Jun; 25(6):576-83. PubMed ID: 26804247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sleep-related breathing disorders - historical development, current status, future prospects].
    Teschler H; Randerath W
    Pneumologie; 2010 Sep; 64(9):583-9. PubMed ID: 20827643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive sleep apnea, hypertension and cardiovascular diseases.
    Gonzaga C; Bertolami A; Bertolami M; Amodeo C; Calhoun D
    J Hum Hypertens; 2015 Dec; 29(12):705-12. PubMed ID: 25761667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.